Cargando…

SP1 transcriptionally regulates UBE2N expression to promote lung adenocarcinoma progression

Lung adenocarcinoma (LUAD) is the main cause of cancer-related death worldwide. Understanding the mechanisms of LUAD progression may provide insights into targeted therapy approaches for this malignancy. Ubiquitin-conjugating enzyme 2 N (UBE2N) has been demonstrated to play key roles in the progress...

Descripción completa

Detalles Bibliográficos
Autores principales:	Li, Jianjun, Qi, Chunchun, Shao, Shanshan, Chen, Yanru, Peng, Zimei, Shen, Qinglin, Zhang, Zhen
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer Nature Singapore 2023
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10039148/ https://www.ncbi.nlm.nih.gov/pubmed/36964266 http://dx.doi.org/10.1186/s43556-023-00118-2

Ejemplares similares

UBE2S promotes the proliferation and survival of human lung adenocarcinoma cells
por: Liu, Zhi, et al.
Publicado: (2018)

Contributions of UBE2C and UBE2S to meiotic progression of porcine oocytes
por: FUJIOKA, Yoshie A., et al.
Publicado: (2018)

UBE2T promotes autophagy via the p53/AMPK/mTOR signaling pathway in lung adenocarcinoma
por: Zhu, Jinhong, et al.
Publicado: (2021)

UBE2V2 promotes metastasis by regulating EMT and predicts a poor prognosis in lung adenocarcinoma
por: Yang, Zheng, et al.
Publicado: (2023)

Prognostic Value of UBE2T and Its Correlation with Immune Infiltrates in Lung Adenocarcinoma
por: Xu, Feng, et al.
Publicado: (2022)

UBE2T regulates FANCI monoubiquitination to promote NSCLC progression by activating EMT
por: Zhang, Jiguang, et al.
Publicado: (2022)

Biochanin A inhibits lung adenocarcinoma progression by targeting ZEB1
por: Li, Jianjun, et al.
Publicado: (2022)

UBE2O targets Mxi1 for ubiquitination and degradation to promote lung cancer progression and radioresistance
por: Huang, Yumei, et al.
Publicado: (2020)

UBE2T knockdown inhibits gastric cancer progression
por: Luo, Changjiang, et al.
Publicado: (2017)

Ube2S regulates Wnt/β-catenin signaling and promotes the progression of non-small cell lung cancer
por: Qin, Yanan, et al.
Publicado: (2020)

ALDOC promotes non-small cell lung cancer through affecting MYC-mediated UBE2N transcription and regulating Wnt/β-catenin pathway
por: Shang, Bin, et al.
Publicado: (2023)

Pan-cancer analysis of UBE2T with a focus on prognostic and immunological roles in lung adenocarcinoma
por: Cao, Kui, et al.
Publicado: (2022)

UBE3A and MCM6 synergistically regulate the proliferation and migration of lung adenocarcinoma cells
por: Luo, Yanyan, et al.
Publicado: (2023)

Knockdown of ubiquitin-conjugating enzyme E2T (UBE2T) suppresses lung adenocarcinoma progression via targeting fibulin-5 (FBLN5)
por: Li, Yi, et al.
Publicado: (2022)

Ube2D3 and Ube2N are essential for RIG-I-mediated MAVS aggregation in antiviral innate immunity
por: Shi, Yuheng, et al.
Publicado: (2017)

Correction: UBE2T knockdown inhibits gastric cancer progression
por: Luo, Changjiang, et al.
Publicado: (2023)

UBE2K regulated by IGF2BP3 promotes cell proliferation and stemness in pancreatic ductal adenocarcinoma
por: Fu, Wen, et al.
Publicado: (2023)

UBE2O Promotes Progression and Epithelial–Mesenchymal Transition in Head and Neck Squamous Cell Carcinoma
por: Chen, Xiyu, et al.
Publicado: (2020)

Oncogenic UBE3C promotes breast cancer progression by activating Wnt/β-catenin signaling
por: Hang, Chen, et al.
Publicado: (2021)

UBE3A activates the NOTCH pathway and promotes esophageal cancer progression by degradation of ZNF185
por: Zheng, Zhikun, et al.
Publicado: (2021)

The interplay of UBE2T and Mule in regulating Wnt/β-catenin activation to promote hepatocellular carcinoma progression
por: Ho, Nicole Pui Yu, et al.
Publicado: (2021)

UBE2J1 inhibits colorectal cancer progression by promoting ubiquitination and degradation of RPS3
por: Wang, Tuo, et al.
Publicado: (2022)

NEDD4L-induced ubiquitination mediating UBE2T degradation inhibits progression of lung adenocarcinoma via PI3K-AKT signaling
por: Chen, Yongbing, et al.
Publicado: (2021)

Pan-Cancer Bioinformatics Analysis of Gene UBE2C
por: Yuan, Lin, et al.
Publicado: (2022)

Circular RNA UBE2Q2 promotes malignant progression of gastric cancer by regulating signal transducer and activator of transcription 3-mediated autophagy and glycolysis
por: Yang, Jing, et al.
Publicado: (2021)

Ubiquitin ligase UBE3C promotes melanoma progression by increasing epithelial-mesenchymal transition in melanoma cells
por: Tang, Li, et al.
Publicado: (2016)

UBE2S promotes the progression and Olaparib resistance of ovarian cancer through Wnt/β-catenin signaling pathway
por: Hu, Wenjing, et al.
Publicado: (2021)

Intrinsic disorder drives N-terminal ubiquitination by Ube2w
por: Vittal, Vinayak, et al.
Publicado: (2014)

UBE2D1 RNA Expression Was an Independent Unfavorable Prognostic Indicator in Lung Adenocarcinoma, but Not in Lung Squamous Cell Carcinoma
por: Hou, Liyan, et al.
Publicado: (2018)

UBE2T promotes glioblastoma malignancy through ubiquitination‐mediated degradation of RPL6
por: Tao, Xuxiu, et al.
Publicado: (2022)

UBE2T promotes proliferation via G2/M checkpoint in hepatocellular carcinoma
por: Liu, Li-Li, et al.
Publicado: (2019)

Ubiquitin Conjugating Enzyme E2 H (UBE2H) Is Linked to Poor Outcomes and Metastasis in Lung Adenocarcinoma
por: Yen, Meng-Chi, et al.
Publicado: (2021)

UBE2T/STAT3 Signaling Promotes the Proliferation and Tumorigenesis in Retinoblastoma
por: Xu, Nuo, et al.
Publicado: (2022)

UBE2C promotes malignancy of cutaneous squamous cell carcinoma
por: Luo, Ruiting, et al.
Publicado: (2023)

Deregulation of UBE2C-mediated autophagy repression aggravates NSCLC progression
por: Guo, Jiwei, et al.
Publicado: (2018)

The clinical significance of UBE2C gene in progression of renal cell carcinoma
por: Chen, Zhiping, et al.
Publicado: (2021)

Upregulation of ubiquitin-conjugating enzyme E2T (UBE2T) predicts poor prognosis and promotes hepatocellular carcinoma progression
por: Ren, Xiaoyue, et al.
Publicado: (2021)

UBE2N plays a pivotal role in maintaining melanoma malignancy
por: Dikshit, Anushka, et al.
Publicado: (2018)

Antibody toolkit reveals N-terminally ubiquitinated substrates of UBE2W
por: Davies, Christopher W., et al.
Publicado: (2021)

UBE2C Is a Transcriptional Target of the Cell Cycle Regulator FOXM1
por: Nicolau-Neto, Pedro, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_rackru4kpo6rq8sjeu0oj84htq